Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab

By afschroeder • October 23, 2025

Karapetians AG, Ayyagari T, Montana W. Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab. Cureus. 2025 Sep 21;17(9):e92816. doi: 10.7759/cureus.92816. PMID: 41127741; PMCID: PMC12538195.

Tags: ebv in hiv positive, ebv positive, ebv ptld, ebv-positive b-cell lymphoproliferative disease, ebv-positive lymphoproliferative disorder, ebv-positive mucocutaneous ulcer, epstein-barr virus (ebv), Hematology/Oncology, Kern, Publications, rituximab monotherapy, rituximab therapy

Related Posts

American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults

O'Dwyer K, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer J, Hayes-Lattin[...]

Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer

Zhang S, Queen KJ, Duggirala N, Yang E, Lipsyc-Sharf M, Racz J, Bennett J, Hong K, Suresh Y, Hamilton C, Pitta M, Chien N, La[...]

Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Choueiri TK, Merchan J, Patnaik A, Drakaki A, Rini BI, Rha SY, Lee JL, Ornstein MC, Kumar R, Hwang C, Shao Y, Park SH, Barata[...]